Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation

Developmental Biology

Volumn 222, Issue 1, 2000, Pages 1-11

  Lai, Yen Tsun ^a   Beason, K Beth ^a   Brames, Gregory P ^a   Desgrosellier, Jay S ^b   Cleggett, Michelle C ^a   Shaw, Marlene V ^c   Brown, Christopher B ^a,b   Barnett, Joey V ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN INDIANA   (United States)

Author keywords

Chick; Development; Epithelial mesenchymal transformation; Heart; Transforming growth factor receptors

Indexed keywords

ACTIVIN RECEPTOR; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; CELL TRANSFORMATION; CHICK EMBRYO; ENDOCARDIUM; EPITHELIUM CELL; HEART DEVELOPMENT; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

GALLUS GALLUS; MAMMALIA;

EID: 0034213609     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.2000.9698     Document Type: Article

References (53)

1. Attisano L., Carcamo J., Venutra F., Weis F. M. B., Massague J., Wrana J. L. Identification of human activin and TGFβ Type I receptors that form heteromeric kinase complexes with Type II receptors. Cell. 75:1993;671-680.
2. Barnett J. V., Moustakas A., Lin W., Fang X.-F., Lin H. Y., Galper J. B., Maas R. L. Cloning and developmental expression of the chick Type II and Type III TGFβ receptors. Dev. Dyn. 199:1994;12-27.
3. Bassing C. H., Yingling J. M., Howe D. J., Wang T., He W. W., Gustafson M. L., Shah P., Donanoe P. K., Wang X.-F. A transforming growth factor β Type I receptor that signals to activate gene expression. Science. 263:1994;87-89.
4. Boyd F. T., Massagué J. Transforming growth factor β inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J. Biol. Chem. 264:1989;2272-2278.
5. Boyer A. S., Ayerinskas I. L., Vincent E. B., McKinney L. A., Weeks D. L., Runyan R. B. TGFβ2 and TGFβ3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev. Biol. 208:1999;530-545.
6. Brown C. B., Boyer A., Runyan R. B., Barnett J. V. Antibodies to the Type II TGFβ receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev. Biol. 174:1996;248-257.
7. Brown C. B., Boyer A., Runyan R. B., Barnett J. V. Requirement of the Type III TGF-β receptor for endocardial cell transformation in the heart. Science. 283:1999a;2980-2082.
8. Brown C. B., Drake C. J., Barnett J. V. Antibodies directed against the chicken Type II TGFβ receptor identify endothelial cells in the developing chicken and quail. Dev. Dyn. 215:1999b;79-85.
9. Cheifetz S., Bellon T., Cales C., Vera S., Bernabeu C., Massague J., Letarte M. Endoglin is a component of the transforming growth factor-β receptor system in human endothelial cells. J. Biol. Chem. 267:1992;19027-19030.
10. Dickson M. C., Slager H. G., Duffie E., Mummery C. L., Akhurst R. J. RNA and protein localisation of TGFβ2 in the early mouse embryo suggest an involvement in cardiac development. Development. 117:1993;625-639.
11. Dudley A. T., Robertson E. J. Overlapping expression domains of bone morphogenetic protein family members potentially account for limited tissue defects in BMP7 deficient embryos. Dev. Dyn. 208:1997;349-362.
12. Ebner R., Chen R.-H., Shum L., Lawler S., Zioncheck T. F., Lee A., Lopez A. R., Derynck R. Cloning of a Type I TGF-β receptor and its effect on TGF-β binding to the Type II receptor. Science. 260:1993a;1344-1348.
13. Ebner R., Chen R.-H., Lawler S., Zioncheck T., Derynck R. Determination of Type I receptor specificity by the Type II receptors for TGF-beta or activin. Science. 262:1993b;900-902.
14. Eisenberg L. M., Markwald R. R. Molecular regulation of atrioventricular valvuloseptal morphogenesis. Circ. Res. 77:1995;1-6.
15. Hamburger V., Hamilton H. L. A series of normal stages in the development of the chick. J. Morphol. 88:1951;49-92.
16. Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Woon S.-J., Stenzel T. T., Speer M., Pericak-Vance M. A., Diamond A., Guttmacher A. E., Jackson C. E., Attisano L., Kucherlapati R., Poteous M. E. M., Marchuk D. A. Mutations in the activin receptor-like kinase 1 gene in hereditary hemorrhagic telangiectasia type 2. Nat. Genet. 13:1996;189-195.
17. Jones C. M., Lyons K. M., Hogan B. L. M. Involvement of bone-morphogenetic protein-4 (BMP-4) and VGR-1 in morphogenesis and neurogenesis in the mouse. Development. 111:1991;531-542.
18. Kingsley D. M., Bland A. E., Grubber J. M., Marker P. C., Russell L. B., Copeland N. G., Jenkins N. A. The mouse short-ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF-beta superfamily. Cell. 71:1992;399-410.
19. Kretzschmar M., Liu F., Hata A., Doody J., Massague J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11:1997;984-995.
20. Kretzschmar M., Massague J. SMADS: Mediators and regulators of TGFβ signaling. Curr. Opin. Genet. Dev. 8:1998;103-111.
21. Laiho M., Weis F. M. B., Massague J. Concomitant loss of transforming growth factor (TGF)-β receptor Types I and II in TGFβ-resistant cell mutants implicates both receptor types in signal transduction. J. Biol. Chem. 265:1990;18518-18524.
22. Laiho M., Weis F. M. B., Boyd F. T., Ignote R. A., Massague J. Responsiveness to transforming growth factor-β (TGFβ) restored by genetic complementation between cells defective in TGFβ receptors I and II. J. Biol. Chem. 266:1991;9108-9112.
23. Lamers W. H., Viragh S., Wessels A., Moorman A. F. M., Anderson R. H. Formation of the tricuspid-valve in the human heart. Circulation. 91:1995;111-121.
24. Lin H. Y., Wang X.-F., Ng-Eaton E., Weinberg R. A., Lodish H. F. Expression cloning of the TGF-β Type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:1992;775-785.
25. Lin H. Y., Moustakas A. TGF-β receptors: Structure and function. Cell. Mol. Biol. 40:1994;337-349.
26. Lopez-Casillas F., Cheifetz S., Doody J., Andres J. L., Lane W. S., Massague J. Structure and expression of the membrane proteoglycan betaglycan, a component of the TGFβ receptor system. Cell. 67:1991;785-795.
27. Lopez-Casillas F., Wrana J. L., Massague J. Betaglycan presents ligand to the TGFβ signaling receptor. Cell. 73:1993;1435-1444.
28. Lopez-Casillas F., Payne H. M., Andres J. L., Massague J. Betaglycan can act as a dual modulator of TGFβ access to signaling receptors: Mapping of ligand binding and GAG attachment sites. J. Cell Biol. 124:1994;557-568.
29. Lux A., Attisano L., Marchuk D. A. Assignment of transforming growth factor β1 and β3 and a third new ligand to the Type I receptor ALK-1. J. Biol. Chem. 274:1999;9984-9992.
30. Lyons K. M., Pelton R. W., Hogan B. L. M. Organogenesis and pattern-formation in the mouse - RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development. 109:1990;833-844.
31. Lyons K. M., Hogan B. L. M., Robertson E. J. Colocalization of BMP-7 and BMP-2 RNAs suggests that these factors cooperatively mediate tissue interactions during murine development. Mech. Dev. 50:1995;71-83.
32. Macias-Silva M., Hoodless P. A., Tang S. J., Buchwald M., Wrana J. L. Specific activation of Smad1 signaling pathways by the BMP7 Type I receptor, ALK2. J. Biol. Chem. 273:1998;25628-25636.
33. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Morrell J., McCormick M. K., Periack-Vance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M., Marchuk D. A. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangectasia type 1. Nat. Genet. 8:1994;345-351.
34. Miettinen P. J., Ebner R., Lopez A. R., Derynck R. TGF-β induced transdifferentiation of mammary epithelial cells to mesenchymal cells: Involvement of Type I receptors. J. Cell Biol. 127:1994;2021-2036.
35. Millan F. A., Denhez F., Kondaiah P., Akhurst R. J. Embryonic gene expression patterns of TGF β1, β2, and β3 suggest different development functions in vivo. Development. 111:1991;131-144.
36. Nohno T., Sumitomo S., Ishikawa T., Ando C., Nishida S., Noji S., Saito T. Nucleotide sequence of a cDNA encoding the chicken receptor protein kinase of the TGF-β receptor family. DNA Seq. J. DNA Seq. Mapp. 3:1993;393-396.
37. Potts J. D., Runyan R. B. Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor. Dev. Biol. 134:1989;392-401.
38. Ramsdell A. F., Markwald R. R. Induction of endocardial cushion tissue in the avian heart is regulated, in part, by TGFβ-3-mediated autocrine signaling. Dev. Biol. 188:1997;64-74.
39. Roberts A. B., Sporn M. B. The transforming growth factor-βs. Sporn M. B., Roberts A. B. Peptide Growth Factors and Their Receptors. 1990;419-472 Springer-Verlag, New York.
40. Roberts A. B., Sporn M. B. Differential expression of the TGF-β isoforms in embryogenesis suggests specific roles in developing and adult tissues. Mol. Reprod. Dev. 32:1992;91-98.
41. Runyan R. B., Markwald R. R. Invasion of mesenchyme into three-dimensional collagen gels: A regional and temporal analysis of interaction in embryonic heart tissue. Dev. Biol. 95:1983;108-114.
42. Sadler T. W. Cardiovascular System in Langman's Medical Embryology. 1985;Williams & Wilkins, Baltimore. p. 168-195.
43. Sanford L. P., Ormsby I., Gittenberger-de Groot A. C., Sariola H., Friedman R., Boivin G. P., Cardell E. L., Doestchman T. TGFβ2 knockout mice have developmental defects that are non overlapping with other TGFβ knockout phenotypes. Development. 124:1997;2659-2670.
44. Solloway M. J., Robertson E. J. Early embryonic lethality in Bmp5;Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development. 126:1999;1753-1768.
45. Towbin H., Staehlin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4353.
46. ten Dijke P., Yamashita H., Ichijo H., Frazen P., Laiho M., Miyazono K., Heldin C.-H. Characterization of Type I receptors for transforming growth factor-β and activin. Science. 264:1994a;101-104.
47. ten Dijke P., Yamashita H., Sampath T. K., Reddi A. H., Estevez M., Riddle D. L., Ichijo H., Heldin C.-H., Miyazono K. Identification of Type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 260:1994b;16985-16988.
48. Wang X.-F., Lin H. Y., Ng-Eaton E., Downward J., Lodish H. F., Weinberg R. A. Expression cloning and characterization of the TGF-β Type III receptor. Cell. 57:1991;861-867.
49. Winnier G., Blessing M., Labosky P. A., Hogan B. L. M. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev. 9:1995;2105-2116.
50. Wrana J. L., Attisano L., Wieser R., Ventura F., Massague J. Mechanism of activation of the TGFβ receptor. Nature. 370:1994;341-347.
51. Yamagishi T., Nakajima Y., Miyazono K., Nakamura H. Bone morphogenetic protein-2 acts synergistically with transforming growth factor-β3 during endothelial-mesenchymal transformation in the developing chick heart. J. Cell. Physiol. 180:1999;35-45.
52. Yamashita H., ten Dijke P., Huylebroeck D., Smapth T. K., Andries M., Smith J. C., Heldin C.-H., Miyazono K. Osteogenic protein-1 binds to activin Type II receptors and induces certain activin-like effects. J. Cell Biol. 130:1995;217-226.
53. Zhang H., Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development. 122:1996;2977-2986.